000 00957 a2200289 4500
005 20250512121658.0
264 0 _c19730301
008 197303s 0 0 eng d
022 _a0003-0465
024 7 _a10.1016/s0003-0465(16)32460-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeaver, W E
245 0 0 _aProtecting our professional prerogatives.
_h[electronic resource]
260 _bJournal of the American Pharmaceutical Association
_cJan 1973
300 _a30-1 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDrug Labeling
650 0 4 _aHumans
650 0 4 _aLegislation, Drug
650 0 4 _aMethadone
650 0 4 _aMethotrexate
650 0 4 _aPharmacists
650 0 4 _aPharmacy
650 0 4 _aUnited States
773 0 _tJournal of the American Pharmaceutical Association
_gvol. 13
_gno. 1
_gp. 30-1
856 4 0 _uhttps://doi.org/10.1016/s0003-0465(16)32460-0
_zAvailable from publisher's website
999 _c4686254
_d4686254